Cue Biopharma, Inc Earning Date (CUE)

USA |NASDAQ |USD

CUE Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 14, 2022 Dec 2021 $-0.35 $-0.41 $-0.36
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 14, 2022 Dec 2021 $4.45M $2.40M $475.32K

Cue Biopharma, Inc's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 2021.

CUE Earnings Date & History Chart

CUE Earnings & Revenue Forecast

CUE Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.35 $-0.45 $-0.20
Mar 2022 3 $-0.43 $-0.51 $-0.36
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-1.47 $-1.60 $-1.34
Dec 2022 5 $-1.78 $-2.07 $-1.48

CUE Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 1 $-0.31 $-0.32 $-0.32
Mar 2022 0 / 0 $-0.41 $-0.40 $-0.40
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 1 $-1.45 $-1.44 $-1.44
Dec 2022 1 / 0 $-1.73 $-1.71 $-1.71

CUE Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $4.45M $2.16M $10.85M
Mar 2022 3 $960.00K $0.00 $2.39M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $10.71M $8.84M $17.54M
Dec 2022 5 $7.05M $0.00 $13.67M

CUE Earnings Date & Revenue History

CUE Earnings History

|
Show More
Show More

CUE Revenue History

|
Show More
Show More

Cue Biopharma, Inc Next Earnings Date & Report

CUE Next Earnings Date & Report Preview: Dec 2021 (FQ)

CUE's next earnings date is Monday, Mar 14, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 4 analysts, the average EPS estimation for Cue Biopharma, Inc's next quarterly earnings is $-0.35, with a low EPS estimation of $-0.45, and a high estimation of $-0.20.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 1 downward. The EPS 1 month trend is $-0.31, the last 2 month trend is $-0.32, and the 3 month trend is $-0.32.

Based on 5 analysts, the average revenue estimation is $4.45M, with a low revenue estimation of $2.16M, and a high estimation of $10.85M.

Cue Biopharma, Inc Previous Earnings Dates & Reports

CUE Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Cue Biopharma, Inc's previous earnings date was Nov 9, 2021 for its fiscal quarter ended Sep 30, 2021.

CUE's earnings per share (EPS) was $-0.41, missing the consensus analysts forecast of $-0.37 by -10.81%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 24.24%, and lower than the same period a year before (Sep 2020) by 20.59%.

Revenues were $2.40M, better than the forecast of $2.05M by 16.83%, down by -12.56% from the previous quarter , and up by 240.20% from the same period last year.

The company reported a net income of $-12.99M.

Free cash flow for the quarter was $-6.64M , compared to $-10.02M last quarter and $-8.03M a year before.

CUE ended the quarter with $3.63M in total debt, a decrease of -25.46% compared to the previous quarter, and a decrease of -55.71% compared to the same quarter a year before.

CUE Previous Earnings Date & Report Recap: Dec 2020 (FY)

Cue Biopharma, Inc's previous annual earnings date was Mar 9, 2021 for its fiscal year ended Dec 31, 2020.

CUE's earnings per share (EPS) was $-1.56, missing the consensus analysts forecast of $-1.53 by 1.96% , and higher than the previous year's EPS (Dec 2019) by -6.59%.

Revenues were $3.15M, worse than the forecast of $4.00M by -21.14%, and down by -8.79% from previous year's revenue.

The company reported a net income of $-44.78M.

Cue Biopharma, Inc reported a free cash flow of $-33.09M for its fiscal year, compared to $-30.84M a year ago.

The company ended the fiscal year with $7.15M in total debt, an increase of 23.30% compared to the previous year.